Bromfenac
Generic Name: bromfenac
Brand Names:
Bromsite 0.075%
Bromfenac ophthalmic solution 0.075% is a sterile topical NSAID indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
Overview
Bromfenac ophthalmic solution 0.075% is a sterile topical NSAID indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
Uses
Indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
Dosage
Apply one drop to the affected eye twice daily (morning and evening) starting 1 day before surgery, continuing surgery day, and for 14 days after.
Side Effects
Most commonly reported adverse reactions (1-8%) were anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, and ocular hypertension.
Warnings
Warnings regarding slow or delayed healing, cross-sensitivity potential, increased bleeding time, keratitis and corneal effects, and contact lens wear restrictions. No specific contraindications listed.
Pregnancy
Use during late pregnancy should be avoided due to prostaglandin biosynthesis-inhibiting drug effects on the fetal cardiovascular system.
Storage
Store at 15 to 25 degrees C (59 to 77 degrees F).
Frequently Asked Questions
What is Bromfenac used for?▼
Indicated for treating postoperative inflammation and preventing ocular pain in patients undergoing cataract surgery.
What are the side effects of Bromfenac?▼
Most commonly reported adverse reactions (1-8%) were anterior chamber inflammation, headache, vitreous floaters, iritis, eye pain, and ocular hypertension.
Can I take Bromfenac during pregnancy?▼
Use during late pregnancy should be avoided due to prostaglandin biosynthesis-inhibiting drug effects on the fetal cardiovascular system.
What are the important warnings for Bromfenac?▼
Warnings regarding slow or delayed healing, cross-sensitivity potential, increased bleeding time, keratitis and corneal effects, and contact lens wear restrictions. No specific contraindications listed.
Related Medications
Trastuzumab-qyyp
trastuzumab-qyyp
HER2/neu Receptor Antagonist [EPC]
11 DESCRIPTION Trastuzumab-qyyp is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Trastuzumab-qyyp is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary) culture. TRAZIMERA (trastuzumab-qyyp) for injection is a sterile, white, preservative-free lyophilized powder with a cake-like appearance, for intravenous administration.
Aluminum Hydroxide, Magnesium Hydroxide, Dimethicone
aluminum hydroxide, magnesium hydroxide, dimethicone
Uses relieves heartburn sour stomach acid indigestion the symptoms referred to as gas
Bromus Ramosus Whole
bromus ramosus whole
Uncertainty, despondency, dissatisfaction.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.